# Hansa Biopharma – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/hansa-biopharma
Company JSON: https://spela.port0.org/company/hansa-biopharma/company.json
Documents JSON: https://spela.port0.org/company/hansa-biopharma/documents.json
Updated: 2026-08-05T23:42:33Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/hansa-biopharma/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/hansa-biopharma/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/hansa-biopharma/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/hansa-biopharma/market/instrument.json
- SEC sammanfattning JSON: https://spela.port0.org/company/hansa-biopharma/market/sec-summary.json
- MFN manifest JSON: https://spela.port0.org/company/hansa-biopharma/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/hansa-biopharma/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/hansa-biopharma/reports
- JSON: https://spela.port0.org/company/hansa-biopharma/reports/reports.json
- 2026 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2026: https://view.news.eu.nasdaq.com/view?id=bede0d6ca3a696c58e3598e2e00f28e88&lang=sv&src=listed
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b6e7ae8326227671800994d5edd916f72&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=bf27172f754e60a7443d9e24540f4d734&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b24e4656c195e7fa770fa95c24b679f75&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=bcc4d4002a3afac4613c92cf153fcffe6&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=be59a800fb78e95341ebbb7d2d873cccc&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=bd966d7a0e436df1dde6f6d4892e81388&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b3f66e0760f0e5922e3d1f4e76da660ff&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=baf73910900f71907e73a2e06e810b725&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=bb5914c933dc4541abbf383b820629d8b&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=bef02c2bdd58381750da47d55f83e0a9c&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=b8a78401bd6b6f50fc99a2eea679a25be&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=bd0aeb8c037245bb23b27782525f84674&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=bb817408be4d6efd33bd1a29052930c3d&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b2040e3695cb897029553b8c36c2dbbe1&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b00495dcd2f0ed6e15197ea39e54c3193&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b6130baf7050bd3f346ace8e7d36342b0&lang=sv&src=listed

## Morningstar Institutions
- Page: https://spela.port0.org/company/hansa-biopharma/morningstar
- Summary: https://spela.port0.org/company/hansa-biopharma/morningstar/summary.txt
- Screenshot: https://spela.port0.org/company/hansa-biopharma/morningstar/screenshot.png

## Finansinspektionen
- Page: https://spela.port0.org/company/hansa-biopharma/finansinspektionen
- Summary: https://spela.port0.org/company/hansa-biopharma/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/hansa-biopharma/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/hansa-biopharma/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/hansa-biopharma/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/hansa-biopharma/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q2 2026: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
  - HTML part 3: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2025/part-003.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
  - HTML part 3: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2024/part-003.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/hansa-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/hansa-biopharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt